¼¼°èÀÇ ½ÉÀå¿ë Àü±Ø ½ÃÀå
Cardiology Electrodes
»óǰÄÚµå : 1752994
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 480 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 7,997,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 23,992,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÉÀå¿ë Àü±Ø ¼¼°è ½ÃÀåÀº 2030³â±îÁö 1¾ï 7,670¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 1¾ï 3,760¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ½ÉÀå¿ë Àü±Ø ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 1¾ï 7,670¸¸ ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 4.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾ÈÁ¤½Ã ECG Àü±ØÀº CAGR 5.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 4,950¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´Ü±â ¸ð´ÏÅ͸µ ECG Àü±Ø ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3,750¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ÉÀå¿ë Àü±Ø ½ÃÀåÀº 2024³â¿¡ 3,750¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2024-2030³â CAGR 7.9%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿©, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 3,650¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.7%¿Í 3.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.5%·Î ÃßÁ¤µË´Ï´Ù.

¼¼°èÀÇ ½ÉÀå¿ë Àü±Ø ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½ÉÀå¿ë Àü±ØÀÌ Áø´Ü ½ÉÀåÇÐ, ¿ø°Ý ¸ð´ÏÅ͸µ, ÇöÀå ½ÉÀå Æò°¡¿¡¼­ Àü·«Àû °ü·Ã¼ºÀ» È®º¸ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½ÉÀå¿ë Àü±ØÀº ÃֽнÉÇ÷°ü Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀ̸ç, ÀÓ»ó ¹× ¿Ü·¡ ȯ°æ¿¡¼­ ½ÉÀåÀÇ »ýü Àü±â ½ÅÈ£¸¦ °¨ÁöÇÏ´Â ÀÎÅÍÆäÀ̽º ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ Àü±ØÀº ½ÉÀüµµ(ECG) µ¥ÀÌÅ͸¦ Á¤È®ÇÏ°Ô ¼öÁýÇÏ¿© ºÎÁ¤¸Æ, ½É±Ù°æ»ö, ÇãÇ÷ ¹× ±âŸ ½ÉÀå ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ßÇϰí Àå±âÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ½ÉÇ÷°ü°è ÁúȯÀÌ Àü ¼¼°è ÀÌȯÀ² ¹× »ç¸Á·ü Åë°è¿¡¼­ ³ôÀº ºñÁßÀ» Â÷ÁöÇϰí ÀÖ´Â °¡¿îµ¥, º´¿ø, Áø´Ü ½ÇÇè½Ç, ¿Ü·¡ ȯÀÚ ¼¾ÅÍ ¹× ÀçÅà ġ·á ȯ°æ¿¡¼­ °íÃæ½Çµµ, ÀÏȸ¿ë ¹× ¿þ¾î·¯ºí Àü±Ø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ½ÉÀåÇÐ, °¡Á¤ °Ç°­ ¸ð´ÏÅ͸µ, µðÁöÅÐ °Ç°­ ÅëÇÕ Áõ°¡·Î ÀÎÇØ ½ÉÀå¿ë Àü±ØÀÇ Àü·«Àû ¿ªÇÒÀÌ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±¸¼º ¿ä¼Ò´Â ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ, ȦÅÍ ½Ã½ºÅÛ, ¸ð¹ÙÀÏ ½ÉÀå ¿ø°Ý ÃøÁ¤ ÀåºñÀÇ ½ÅÈ£ Á¤È®µµ¸¦ º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ºñ¿ë È¿À²¼º, »ç¿ë ÆíÀǼº, ±Þ¼º±â ¹× ¸¸¼º±â ÀÇ·á¿¡¼­ ½ÉÀå ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ´Â ¿ªÇÒ·Î ÀÎÇØ ¿¹¹æ, Áø´Ü ¹× Åð¿ø ÈÄ È¯°æ¿¡¼­ äÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Àç·áÀÇ ¹ßÀü, Æû ÆÑÅÍÀÇ Çõ½Å, ¹«¼± ÅëÇÕÀº ½ÉÀå¿ë Àü±ØÀÇ ¼º´ÉÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

Àü±Ø ¼³°è ¹× Àç·áÀÇ ±â¼úÀû °³¼±Àº ½ÅÈ£ ǰÁú, ȯÀÚ ÆíÀǼº ¹× Àå½Ã°£ Âø¿ë ³»±¸¼º¿¡¼­ ¼º´É Çâ»óÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Àº/¿°È­Àº(Ag/AgCl)Àº ¿ì¼öÇÑ ½ÅÈ£ Àü´Þ°ú ¾ÈÁ¤¼ºÀ¸·Î ÀÎÇØ ¿©ÀüÈ÷ Ç¥ÁØ Àüµµ¼º ¸Åü·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÇÏÀ̵å·Î°Ö Á¢ÂøÁ¦¿Í Åë±â¼º ¹éÅ·ÀÇ ±â¼ú Çõ½ÅÀ¸·Î ÇǺΠÀûÇÕ¼ºÀÌ Çâ»óµÇ¾î Àå½Ã°£ »ç¿ë ½Ã ÀÚ±ØÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

°ÖÈ­ Àü ÀÏȸ¿ë Àü±ØÀº ÀÀ±Þ ¹× ±Þ¼º±â ÀÇ·á ÇöÀå¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹Ý¸é, °ÖÈ­µÇÁö ¾ÊÀº °Ç½Ä Àü±ØÀº À¯Áöº¸¼ö¸¦ ÁÙÀ̰í Àç»ç¿ëÀÌ °¡´ÉÇϱ⠶§¹®¿¡ Âø¿ëÇü ECG ¿ëµµ¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. À¯¿¬ÇÏ°í ¾ãÀº Àü±Ø°ú ³ôÀº ÀûÇÕ¼º ±âÆÇÀº ¿îµ¿¼±¼ö¿Í ¼Ò¾Æ°ú Àǻ簡 »ç¿ëÇÏ´Â ½Åü À±°û µðÀÚÀÎÀ» Áö¿øÇϸç, ºí·çÅõ½º ¹× Wi-Fi Áö¿ø ECG ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ» ÅëÇØ Àü±ØÀÇ ¹èÄ¡¿Í »ç¿ëÀÚÀÇ À̵¿¼ºÀ» ÇØÄ¡Áö ¾Ê°í ½ÉÀå ½ÅÈ£¸¦ ½Ç½Ã°£À¸·Î Àü¼ÛÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °¡´ÉÇØÁö°í ÀÖ½À´Ï´Ù.

½ºÅ©¸° ÀÎ¼â ¹× ·ÑÅõ·Ñ »ý»ê°ú °°Àº ÷´Ü Á¦Á¶ ±â¼úÀº ºñ¿ëÀ» ³·Ãß°í, ÆÐÄ¡ Àü±Ø, ÈäºÎ º§Æ®, »çÁö¿ë ¸®µå¼± µî ȯÀÚ »óÅÂ, »ç¿ë ±â°£, Ä¡·á ȯ°æ¿¡ µû¶ó ƯÁ¤ ÆûÆÑÅÍ¿¡ ´ëÇÑ ´ë±Ô¸ð ¸ÂÃãÈ­¸¦ Áö¿øÇÕ´Ï´Ù.

½ÉÀ庴¿ë Àü±Ø ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª ½ÃÀå, ÇコÄÉ¾î ¸ðµ¨Àº ¹«¾ùÀΰ¡?

º´¿ø°ú ½ÉÀå Àü¹® Ŭ¸®´ÐÀº ¿©ÀüÈ÷ ½ÉÀå¿ë Àü±ØÀÇ ÃÖ´ë »ç¿ëÀÚÀ̸ç, ȯÀÚ ¼ö°¡ ¸¹°í ÈÞ½Ä, ºÎÇÏ ¹× ȦÅÍ ECG ÀýÂ÷¿¡¼­ ÀÏ»óÀûÀÎ »ç¿ëÀÌ ±× ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª Áö¼ÓÀûÀÎ µ¥ÀÌÅÍ ¼öÁýÀ» À§ÇØ Àü±ØÀ» ¿þ¾î·¯ºí ¹× ¸ð¹ÙÀÏ ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ´Â ¿Ü·¡ Áø·á, ÀçÅÃÄ¡·á ¸ð´ÏÅ͸µ, ¿ø°Ý Áø´Ü ºÐ¾ß¿¡¼­µµ Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº CVD À¯º´·ü, ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µÀÇ º¸±ÞÀ¸·Î ÀÎÇØ º¸±Þ·ü¿¡¼­ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. À¯·´Àº ¿Ü·¡ ECG ¼­ºñ½º¿¡ ´ëÇÑ »óȯ ÇÁ·¹ÀÓ¿öÅ©¿Í Àα¸ Åë°èÇÐÀû °í·ÉÈ­ Ãß¼¼¿¡ ÈûÀÔ¾î À¯·´ÀÌ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÉÀå Áø´Ü¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë, ¸ð¹ÙÀÏ Çコ, ¿¹¹æÀû ½ÉÀå °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

Á¶±â ¹ß°ß, ÀçÀÔ¿ø °¨¼Ò, ¸¸¼ºÁúȯ °ü¸® ÃÖÀûÈ­¿¡ ÁßÁ¡À» µÐ ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨¿¡¼­´Â Àü±ØÀÇ ½Å·Ú¼º°ú ½ÅÈ£ Á¤È®µµ°¡ ¹Ì¼Ç Å©¸®Æ¼ÄÃÇÑ ¿ø°Ý ½ÉÀüµµ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÆÄÆ®³Ê½ÊÀ» ¸Î°í ¿Ü·¡ ȯÀÚ ¹× °¡Á¤ ³» ¹èÄ¡¿¡ ÀûÇÕÇÑ °í¼º´É Àü±ØÀ» »ç¿ëÇÏ´Â ÅëÇÕ ½Ã½ºÅÛÀ» °øµ¿ °³¹ßÇϰí ÀÖ½À´Ï´Ù.

½ÉÀå¿ë Àü±Ø ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

½ÉÀå¿ë Àü±Ø ½ÃÀåÀº ±Þ¼º±â ÀÇ·á, ¸¸¼ºÁúȯ °ü¸® ¹× ¿¹¹æÀû °ËÁø¿¡¼­ Á¤È®ÇÏ°í ºñħ½ÀÀûÀÎ ½ÉÀå ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÇϰí ÀÖÀ¸¸ç, ECG ±â¹Ý ±â¼úÀÇ µ¥ÀÌÅÍ ¼öÁý¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ÀÌ Á¦Ç°Àº ´Ù¾çÇÑ Áø´Ü ¹× µðÁöÅÐ ½ÉÀåÇÐ ¼Ö·ç¼ÇÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â Àü ¼¼°è ½ÉÇ÷°ü Áúȯ ºÎ´ã Áõ°¡, ¿þ¾î·¯ºí ¹× ¿ø°Ý ½ÉÀüµµ ±â¼ú äÅà Ȯ´ë, »ýü ÀûÇÕ¼º ¼ÒÀç ¹× Àú¼ÒÀ½ Àü±Ø ¼³°è Çõ½Å, ºÐ»êÇü Áø·á ¸ðµ¨¿¡ ½ÉÀå Áø´ÜÀÇ ±¤¹üÀ§ÇÑ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù. ÀçÅà ½ÉÀå ¿ø°Ý ÃøÁ¤¿¡ ´ëÇÑ ±ÔÁ¦Àû Áö¿ø°ú ½ÉÀüµµ ÇØ¼®¿¡ ´ëÇÑ AI Ȱ¿ë È®´ë´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â Àü±Ø ÀÎÅÍÆäÀ̽º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

½ÉÀåÇÐÀÌ ½Ç½Ã°£, ȯÀÚ Áß½É, µðÁöÅÐ Áö¿ø ¸ð´ÏÅ͸µ ÇÁ·¹ÀÓ¿öÅ©·Î ÀüȯÇÏ´Â °¡¿îµ¥, Àü±ØÀÌ Â÷¼¼´ë ÀÇ·á ½Ã½ºÅÛ¿¡¼­ È®Àå °¡´ÉÇÑ °íÇØ»óµµ ½ÉÀå Áø´ÜÀÇ ÇÙ½ÉÀÌ µÉ ¼ö ÀÖÀ»±î?

ºÎ¹®

Á¦Ç° À¯Çü(¾ÈÁ¤½Ã ECG Àü±Ø, ´Ü±â ¸ð´ÏÅ͸µ ECG Àü±Ø, Àå±â ¸ð´ÏÅ͸µ ECG Àü±Ø, ½ºÆ®·¹½º Å×½ºÆ® ECG Àü±Ø, ½Å»ý¾Æ ECG Àü±Ø, ¼Ò¾Æ ECG Àü±Ø), ÁÖ¹® À¯Çü(Á¡Âø¼º °Ö ½ÉÀå¿ë Àü±Ø, ½ÀÀ± °Ö ½ÉÀå¿ë Àü±Ø, °ÇÁ¶ ½ÉÀå¿ë Àü±Ø, °íÇü °Ö ½ÉÀå¿ë Àü±Ø);»ç¿ë¼º(ÀÏȸ¿ë ÀÇ·á¿ë Àü±Ø, ÀçÀÌ¿ë °¡´É ÀÇ·á¿ë Àü±Ø);ÃÖÁ¾ ¿ëµµ(º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 42°³»ç)

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiology Electrodes Market to Reach US$176.7 Million by 2030

The global market for Cardiology Electrodes estimated at US$137.6 Million in the year 2024, is expected to reach US$176.7 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Resting ECG Electrodes, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$49.5 Million by the end of the analysis period. Growth in the Short-Term Monitoring ECG Electrodes segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$37.5 Million While China is Forecast to Grow at 7.9% CAGR

The Cardiology Electrodes market in the U.S. is estimated at US$37.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$36.5 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Cardiology Electrodes Market - Key Trends & Drivers Summarized

Why Are Cardiology Electrodes Gaining Strategic Relevance Across Diagnostic Cardiology, Remote Monitoring, and Point-of-Care Cardiac Assessment?

Cardiology electrodes are integral to modern cardiovascular diagnostics and monitoring, serving as the interface for detecting bioelectric signals from the heart in both clinical and ambulatory settings. These electrodes enable precise acquisition of electrocardiogram (ECG) data, facilitating early detection and long-term management of arrhythmias, myocardial infarction, ischemia, and other cardiac abnormalities. As cardiovascular disease continues to lead global morbidity and mortality statistics, demand for high-fidelity, disposable, and wearable electrodes is increasing across hospitals, diagnostic labs, ambulatory centers, and home-based care environments.

The rise in telecardiology, home health monitoring, and digital health integration is further elevating the strategic role of cardiology electrodes. These components are essential for ensuring signal accuracy in wearable ECG monitors, Holter systems, and mobile cardiac telemetry devices. Their cost-effectiveness, ease of use, and role in streamlining cardiac workflow across acute and chronic care are reinforcing their adoption in preventive, diagnostic, and post-discharge settings.

How Are Material Advancements, Form Factor Innovations, and Wireless Integration Enhancing Cardiology Electrode Performance?

Technological improvements in electrode design and materials are driving performance gains in signal quality, patient comfort, and long-wear durability. Silver/silver chloride (Ag/AgCl) remains the standard conductive medium due to its excellent signal transduction and stability, while innovations in hydrogel adhesives and breathable backings are enhancing skin compatibility and minimizing irritation during prolonged use.

Pre-gelled disposable electrodes are seeing increased usage in emergency and acute care scenarios, while dry, non-gelled electrodes are gaining ground in wearable ECG applications due to reduced maintenance and improved reusability. Flexible, low-profile electrodes with conformable substrates are supporting body-contouring designs for athletic and pediatric use. Integration with Bluetooth and Wi-Fi-enabled ECG systems is enabling real-time transmission of cardiac signals without compromising electrode placement or user mobility.

Advanced manufacturing techniques such as screen printing and roll-to-roll production are lowering costs and supporting large-scale customization for specific form factors-including patch electrodes, chest belts, and limb leads tailored to patient condition, duration of use, and care setting.

Which End-Use Settings, Regional Markets, and Healthcare Models Are Driving Cardiology Electrode Market Expansion?

Hospitals and cardiac specialty clinics remain the largest users of cardiology electrodes, driven by high patient volumes and routine use in resting, stress, and Holter ECG procedures. However, significant growth is occurring in ambulatory care, home health monitoring, and remote diagnostics, where electrodes are embedded in wearables and mobile telemetry systems for continuous data collection.

North America leads in adoption due to advanced healthcare infrastructure, high CVD prevalence, and widespread use of telehealth and remote cardiac monitoring. Europe follows closely, supported by reimbursement frameworks for ambulatory ECG services and aging demographics. Asia-Pacific is witnessing rapid growth driven by expanding access to diagnostic cardiology, mobile health initiatives, and rising awareness of preventive cardiac care.

Healthcare delivery models emphasizing early detection, reduced readmissions, and chronic care optimization are increasingly relying on remote ECG monitoring solutions, where electrode reliability and signal accuracy are mission-critical. OEMs, digital health startups, and cardiac device manufacturers are forming strategic partnerships to co-develop integrated systems using high-performance electrodes tailored for outpatient and at-home deployment.

What Are the Factors Driving Growth in the Cardiology Electrodes Market?

The cardiology electrodes market is expanding as demand intensifies for accurate, non-invasive cardiac monitoring across acute care, chronic disease management, and preventive screening. Their critical role in data acquisition for ECG-based technologies underpins a wide array of diagnostic and digital cardiology solutions.

Key growth drivers include the global rise in cardiovascular disease burden, increasing adoption of wearable and remote ECG technologies, innovation in biocompatible materials and low-noise electrode design, and broader integration of cardiac diagnostics into decentralized care models. Regulatory support for at-home cardiac telemetry and expanding use of AI in ECG interpretation are further reinforcing demand for reliable electrode interfaces.

As cardiology shifts toward real-time, patient-centric, and digitally-enabled monitoring frameworks, could electrodes become the linchpin of scalable, high-resolution cardiac diagnostics in next-generation health systems?

SCOPE OF STUDY:

The report analyzes the Cardiology Electrodes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Resting ECG Electrodes, Short-Term Monitoring ECG Electrodes, Long-Term Monitoring ECG Electrodes, Stress Test ECG Electrode, Neonatal ECG Electrodes, Pediatric ECG Electrodes); Order Type (Sticky Gel Cardiology Electrodes, Wet Gel Cardiology Electrodes, Dry Cardiology Electrodes, Solid Gel Cardiology Electrodes); Usability (Disposable Medical Electrodes, Reusable Medical Electrodes); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â